BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24631895)

  • 1. 1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity.
    Abdel-Aziz M; Beshr EA; Abdel-Rahman IM; Ozadali K; Tan OU; Aly OM
    Eur J Med Chem; 2014 Apr; 77():155-65. PubMed ID: 24631895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies.
    Abuo-Rahma Gel-D; Abdel-Aziz M; Farag NA; Kaoud TS
    Eur J Med Chem; 2014 Aug; 83():398-408. PubMed ID: 24983538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New indomethacin analogs as selective COX-2 inhibitors: Synthesis, COX-1/2 inhibitory activity, anti-inflammatory, ulcerogenicity, histopathological, and docking studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; El-Nahass ES; Abdel-Fattah MM; Abdelgawad YYM
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000328. PubMed ID: 33314237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
    Abdel-Aziz AA; ElTahir KE; Asiri YA
    Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
    Abdelrahman MH; Youssif BGM; Abdelgawad MA; Abdelazeem AH; Ibrahim HM; Moustafa AEGA; Treamblu L; Bukhari SNA
    Eur J Med Chem; 2017 Feb; 127():972-985. PubMed ID: 27837994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives.
    Bakr RB; Azouz AA; Abdellatif KR
    J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
    Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
    Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
    Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity.
    Yamakawa N; Suemasu S; Okamoto Y; Tanaka K; Ishihara T; Asano T; Miyata K; Otsuka M; Mizushima T
    J Med Chem; 2012 Jun; 55(11):5143-50. PubMed ID: 22404396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents.
    Alegaon SG; Alagawadi KR; Garg MK; Dushyant K; Vinod D
    Bioorg Chem; 2014 Jun; 54():51-9. PubMed ID: 24793214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
    Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
    Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies.
    Abdel-Aziz AA; El-Azab AS; Abou-Zeid LA; ElTahir KE; Abdel-Aziz NI; Ayyad RR; Al-Obaid AM
    Eur J Med Chem; 2016 Jun; 115():121-31. PubMed ID: 26999325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
    Khalil NA; Ahmed EM; Mohamed KO; Nissan YM; Zaitone SA
    Bioorg Med Chem; 2014 Apr; 22(7):2080-9. PubMed ID: 24631365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
    Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
    Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel 1,2,3-triazole based benzoxazolinones: their TNF-α based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation.
    Haider S; Alam MS; Hamid H; Shafi S; Nargotra A; Mahajan P; Nazreen S; Kalle AM; Kharbanda C; Ali Y; Alam A; Panda AK
    Eur J Med Chem; 2013; 70():579-88. PubMed ID: 24211633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles.
    Faidallah HM; Rostom SAF
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity.
    Halim PA; Georgey HH; George MY; El Kerdawy AM; Said MF
    Bioorg Chem; 2021 Oct; 115():105253. PubMed ID: 34390973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory-antimicrobial agents and their docking studies with COX-1/COX-2 active sites.
    Chandak N; Kumar P; Kaushik P; Varshney P; Sharma C; Kaushik D; Jain S; Aneja KR; Sharma PK
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):476-84. PubMed ID: 23777557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of antioxidant properties of some 6-(alpha-aminobenzyl)thiazolo[3,2-b]-1,2,4-triazole-5-ol compounds.
    Aktay G; Tozkoparan B; Ertan M
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):898-902. PubMed ID: 18951285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.